Cargando…
Glomerular filtration rate is the main predictor of urine volume in autosomal dominant polycystic kidney disease patients treated with tolvaptan when daily osmolar excretion is expressed as urinary osmolality/creatinine ratio
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986321/ https://www.ncbi.nlm.nih.gov/pubmed/33777387 http://dx.doi.org/10.1093/ckj/sfaa171 |
_version_ | 1783668421512134656 |
---|---|
author | Borrego Utiel, Francisco José Merino García, Enoc |
author_facet | Borrego Utiel, Francisco José Merino García, Enoc |
author_sort | Borrego Utiel, Francisco José |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7986321 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-79863212021-03-26 Glomerular filtration rate is the main predictor of urine volume in autosomal dominant polycystic kidney disease patients treated with tolvaptan when daily osmolar excretion is expressed as urinary osmolality/creatinine ratio Borrego Utiel, Francisco José Merino García, Enoc Clin Kidney J Letters to the Editor Oxford University Press 2020-10-21 /pmc/articles/PMC7986321/ /pubmed/33777387 http://dx.doi.org/10.1093/ckj/sfaa171 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of ERA-EDTA. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Letters to the Editor Borrego Utiel, Francisco José Merino García, Enoc Glomerular filtration rate is the main predictor of urine volume in autosomal dominant polycystic kidney disease patients treated with tolvaptan when daily osmolar excretion is expressed as urinary osmolality/creatinine ratio |
title | Glomerular filtration rate is the main predictor of urine volume in autosomal dominant polycystic kidney disease patients treated with tolvaptan when daily osmolar excretion is expressed as urinary osmolality/creatinine ratio |
title_full | Glomerular filtration rate is the main predictor of urine volume in autosomal dominant polycystic kidney disease patients treated with tolvaptan when daily osmolar excretion is expressed as urinary osmolality/creatinine ratio |
title_fullStr | Glomerular filtration rate is the main predictor of urine volume in autosomal dominant polycystic kidney disease patients treated with tolvaptan when daily osmolar excretion is expressed as urinary osmolality/creatinine ratio |
title_full_unstemmed | Glomerular filtration rate is the main predictor of urine volume in autosomal dominant polycystic kidney disease patients treated with tolvaptan when daily osmolar excretion is expressed as urinary osmolality/creatinine ratio |
title_short | Glomerular filtration rate is the main predictor of urine volume in autosomal dominant polycystic kidney disease patients treated with tolvaptan when daily osmolar excretion is expressed as urinary osmolality/creatinine ratio |
title_sort | glomerular filtration rate is the main predictor of urine volume in autosomal dominant polycystic kidney disease patients treated with tolvaptan when daily osmolar excretion is expressed as urinary osmolality/creatinine ratio |
topic | Letters to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986321/ https://www.ncbi.nlm.nih.gov/pubmed/33777387 http://dx.doi.org/10.1093/ckj/sfaa171 |
work_keys_str_mv | AT borregoutielfranciscojose glomerularfiltrationrateisthemainpredictorofurinevolumeinautosomaldominantpolycystickidneydiseasepatientstreatedwithtolvaptanwhendailyosmolarexcretionisexpressedasurinaryosmolalitycreatinineratio AT merinogarciaenoc glomerularfiltrationrateisthemainpredictorofurinevolumeinautosomaldominantpolycystickidneydiseasepatientstreatedwithtolvaptanwhendailyosmolarexcretionisexpressedasurinaryosmolalitycreatinineratio |